Literature DB >> 17922098

Experience of gastric cancer in a patient who had received a living-donor liver transplantation.

Yasuhiro Nagata1, Susumu Eguchi, Mitsuhisa Takatsuki, Akihito Enjoji, Tatsuki Ichikawa, Tomayoshi Hayashi, Takashi Kanematsu.   

Abstract

A 57-year-old woman had previously undergone a living-donor liver transplantation (LDLT) for end-stage liver disease related to hepatitis B virus. The liver graft had been donated by her husband. Her postoperative course had been uneventful. In the course of postoperative surveillance, she was incidentally found to have gastric cancer by an endoscopic examination 2 years after the liver transplantation. A gastric resection was the treatment choice, and the results were successful. The tumor, which was moderately differentiated adenocarcinoma, was limited to the mucosal layer, with no metastasis. In addition, a Helicobacter pylori infection was observed. This is the first reported case of a gastric cancer after LDLT. We report this case because of its importance regarding the need to carry out close surveillance in transplant recipients who are treated with immunosuppressive drugs, in order to make a timely identification of the occurrence of common malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922098     DOI: 10.1007/s10120-007-0428-5

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  6 in total

Review 1.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

2.  Incidental diagnosis of gastric cancer in transplant recipients improves patient survival.

Authors:  Joseph F Buell; Thomas Husted; Michael J Hanaway; V Ram Peddi; Jennifer Trofe; Thomas G Gross; Thomas M Beebe; M Roy First; E Steve Woodle
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

Review 3.  Malignancy after transplantation.

Authors:  Joseph F Buell; Thomas G Gross; E Steve Woodle
Journal:  Transplantation       Date:  2005-10-15       Impact factor: 4.939

Review 4.  Interferon-gamma and cancer immunoediting.

Authors:  Gavin P Dunn; Hiroaki Ikeda; Allen T Bruce; Catherine Koebel; Ravi Uppaluri; Jack Bui; Ruby Chan; Mark Diamond; J Michael White; Kathleen C F Sheehan; Robert D Schreiber
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy.

Authors:  Joseph F Buell; T Husted; M J Hanaway; J Trofe; T Gross; T Beebe; M R First; E S Woodle
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

Review 6.  Post-transplant malignancy: the role of immunosuppression.

Authors:  I Penn
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.228

  6 in total
  3 in total

1.  Totally Laparoscopic Distal Gastrectomy in Post Liver Transplant Patient.

Authors:  Eun Young Park; Dong Jin Park; Hyung Woo Park; Chang Woo Nam; Yang Won Nah; Gyu Yeol Kim
Journal:  J Minim Invasive Surg       Date:  2019-03-15

2.  Lessons Learned From a Case of Gastric Cancer After Liver Transplantation for Hepatocellular Carcinoma: A Case Report and Literatures Review.

Authors:  Kun Yang; Hong Zhu; Chong-Cheng Chen; Tian-Fu Wen; Wei-Han Zhang; Kai Liu; Xin-Zu Chen; Dong-Jiao Guo; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

3.  Robotic surgical system completed radical gastrectomy for gastric cancer after liver transplantation: case report and systematic review.

Authors:  Qian Chen; Junyan Fan; Junyan Liu; Chuan Li; Jiajia Liu; Feng Qian
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.